ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $100 | -31.5% | 863 | 0.0% | 0.00% | – |
Q4 2022 | $146 | – | 863 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 863 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 863 | 0.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 863 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 863 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 863 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 863 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | – | 863 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 863 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 863 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 863 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 863 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 863 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 863 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 863 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 863 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | 0.0% | 863 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | 0.0% | 863 | 0.0% | 0.00% | – |
Q1 2018 | $3,000 | 0.0% | 863 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | +50.0% | 863 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | – | 863 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
A.R.T. Advisors, LLC | 20,419 | $16,000 | 0.09% |
Maven Securities LTD | 1,000,000 | $795,000 | 0.07% |
Verdence Capital Advisors LLC | 88,382 | $69,000 | 0.02% |
Hayden Royal, LLC | 26,000 | $20,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 55,752 | $44,000 | 0.01% |
Qube Research & Technologies Ltd | 519,063 | $407,000 | 0.01% |
Virtu Financial LLC | 39,683 | $31,000 | 0.01% |
Global Strategic Investment Solutions, LLC | 23,000 | $18,000 | 0.01% |
Jacobi Capital Management LLC | 25,000 | $20,000 | 0.00% |
RVW Wealth, LLC | 19,000 | $15,000 | 0.00% |